SYRA HEALTH CORP. (SYRA) Return on equity 2022–2025
SYRA HEALTH CORP. (SYRA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-42.7%FY2025 · since FY2022: -298.3% → -42.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -42.7% | +87.9 pp |
| FY2024 | -130.6% | -57.4 pp |
| FY2023 | -73.2% | +225.1 pp |
| FY2022 | -298.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More SYRA financial trends
SYRA RevenueSYRA Net incomeSYRA Net marginSYRA Gross profitSYRA Gross marginSYRA Operating incomeSYRA Operating marginSYRA Operating cash flowSYRA Free cash flowSYRA Capital expendituresSYRA Stock buybacksSYRA Dividends paidSYRA Total assetsSYRA Total liabilitiesSYRA Shareholders’ equitySYRA overview →